Form 4 for ZLAB Zai Lab Ltd
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-14 · accession 0000905148-24-001470 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-05-16 | 2024-05-14 | ZLAB | Edmondson Frazor Titus III | CLO | S - Sale | $21.33 | -10.0K | 16.4K | -38% | -$213.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2024-05-14 | S | D | 10,000 | $21.33 | 16,408 | D | — | — | (F1) Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. (F3) Reflects a weighted average sale price of $21.3346 per share, at prices ranging from $21.025 to $21.625 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |